<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncotarget</journal-id><journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">ImpactJ</journal-id><journal-title-group><journal-title>Oncotarget</journal-title></journal-title-group><issn pub-type="epub">1949-2553</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29844862</article-id><article-id pub-id-type="pmc">5963630</article-id><article-id pub-id-type="publisher-id">23673</article-id><article-id pub-id-type="doi">10.18632/oncotarget.23673</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>Genetic variants in lncRNA <italic>H19</italic> are associated with the risk of oral squamous cell carcinoma in a Chinese population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Zhiyao</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Miao</surname><given-names>Limin</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lihua</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Keke</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ji</surname><given-names>Yefeng</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ruixia</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Hongxia</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Ning</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Hua</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><aff id="A1"><sup>1</sup> Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China</aff><aff id="A2"><sup>2</sup> Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China</aff><aff id="A3"><sup>3</sup> Department of Epidemiology and Biostatistics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China</aff></contrib-group><author-notes><corresp id="cor1"><bold><italic>Correspondence to</italic></bold><italic>: Ning Chen,</italic><email>ningchen09@gmail.com</email></corresp><corresp id="cor2"><italic>Hua Yuan,</italic><email>yuanhua@njmu.edu.cn</email></corresp><fn fn-type="equal" id="FN1"><label>*</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date pub-type="collection"><day>8</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>2</day><month>1</month><year>2018</year></pub-date><volume>9</volume><issue>35</issue><fpage>23915</fpage><lpage>23922</lpage><history><date date-type="received"><day>14</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2018 Yuan et al.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>To evaluate whether the genetic variants in <italic>H19</italic> influence the risk of oral squamous cell carcinoma (OSCC) in a Chinese population, a case-control study was conducted to analyze four functional single nucleotide polymorphisms (SNPs) in <italic>H19</italic>. The cohort comprised of 444 OSCC cases and 984 healthy controls, and the study further evaluated the biological effect by bioinformatics prediction and functional experiments. Two SNPs, rs217727 and rs2839701, were found to be associated with the risk of OSCC [rs217727: odds ratio (OR) = 1.32, 95% confidence interval (CI) = 1.11&#x02013;1.58, <italic>P</italic> = 0.002; rs2839701: OR = 1.23, 95% CI = 1.04&#x02013;1.46, <italic>P</italic> = 0.019].Bioinformatics predicted that rs2839701 C&#x0003e;G might alter the secondary structure of <italic>H19</italic>. In addition, rs2839701 C&#x0003e;G inhibited the transcription activity and was correlated with the decreased expression of downstream gene <italic>MRPL23-AS1</italic> that was downregulated in OSCC. The current results suggested that the SNPs in H19 may play a major role in genetic susceptibility to OSCC.</p></abstract><kwd-group><kwd>lncRNAs</kwd><kwd>H19</kwd><kwd>oral squamous cell carcinoma</kwd><kwd>genetic variants</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>INTRODUCTION</title><p>Oral squamous cell carcinoma (OSCC) is a severe disease worldwide, with high morbidity and 5-year mortality of about 50% [<xref rid="R1" ref-type="bibr">1</xref>]. In China, an estimated 48,100 incidents and 22,100 death cases due to oral and pharynx cancer were reported in 2015 [<xref rid="R2" ref-type="bibr">2</xref>]. Smoking and alcohol consumption are the main environmental factors affecting the development of OSCC [<xref rid="R3" ref-type="bibr">3</xref>], although genetic variants also play vital roles in oral carcinogenesis [<xref rid="R4" ref-type="bibr">4</xref>]. Hitherto, two genome-wide association studies (GWAS) have revealed several oral cancer susceptibility loci [<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R6" ref-type="bibr">6</xref>]; however, there is yet much of heritability unexplained. Therefore, the remaining unidentified heritability necessitates further investigation.</p><p>Long non-coding RNAs (lncRNAs) are defined as RNAs &#x0003e; 200 nucleotides in length and those without encoding proteins; these could serve as transcriptional and post-transcriptional regulators in carcinogenesis [<xref rid="R7" ref-type="bibr">7</xref>]. <italic>H19</italic> is one of the lncRNAs that participates in the development and progression of malignancies [<xref rid="R8" ref-type="bibr">8</xref>]. Several studies have shown aberrant expression of <italic>H19</italic> in multiple cancers including squamous cell carcinoma of head and neck [<xref rid="R9" ref-type="bibr">9</xref>]. <italic>H19</italic> may participate in tumorigenesis and progression by acting as competing endogenous RNA (ceRNA) [<xref rid="R10" ref-type="bibr">10</xref>] or the precursor of microRNA [<xref rid="R11" ref-type="bibr">11</xref>]. For example, <italic>H19</italic> could promote the development of gallbladder cancer by competitively binding miR-342-3p to regulate the expression of FOXM1 [<xref rid="R12" ref-type="bibr">12</xref>]. Micro RNA (miRNA)-675, encoded by exon1 of <italic>H19</italic>, enhances the proliferation and invasion of gastric cancer via tumor suppressor <italic>RUNX1</italic> [<xref rid="R13" ref-type="bibr">13</xref>].</p><p>Single-nucleotide polymorphism (SNP) is a kind of genetic variation that might influence gene expression and mRNA conformation, thereby affecting the function of the gene and disease phenotype [<xref rid="R14" ref-type="bibr">14</xref>]. With the development of bioinformatics, unique datasets and prediction software have provided exhaustive data for gene function and expression influenced by functional SNPs. For example, the Genotype-Tissue Expression (GTEx) Project has established a tissue bank for studying the association of genetic variations in gene expression in various tissues or organs of a human body, thereby providing evidence for the expression quantitative trait loci (eQTL) [<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. The Encyclopedia of DNA Elements Consortium (ENCODE) provides information of functional regulatory elements in the whole human genome [<xref rid="R17" ref-type="bibr">17</xref>]. Recently, SNPs in lncRNAs have gained increasing attention for their physiological regulatory functions. The genetic variants of <italic>H19</italic> have been identified to be associated with the susceptibility to breast cancer [<xref rid="R18" ref-type="bibr">18</xref>], bladder cancer [<xref rid="R19" ref-type="bibr">19</xref>], gastric cancer [<xref rid="R20" ref-type="bibr">20</xref>], and colorectal cancer [<xref rid="R21" ref-type="bibr">21</xref>]. However, there is no study addressing the relationship between genetic variations of <italic>H19</italic> and OSCC risk in Chinese population.</p><p>Therefore, we hypothesized that functional SNPs of <italic>H19</italic> might influence the physiological function of <italic>H19</italic> or the expression of cancer-related genes, thereby contributing to the development of OSCC. To confirm this hypothesis, a case&#x02013;control study was conducted to evaluate the associations between functional SNPs of <italic>H19</italic> and OSCC risk using a cohort of 444 cases and 984 controls, and further evaluating the physiological effect by bioinformatics prediction and functional experiments.</p></sec><sec id="s2"><title>RESULTS</title><sec id="s2_1"><title>General characteristics of participants</title><p>The distributions of selected variables in the study subjects are characterized in Table <xref ref-type="table" rid="T1">1</xref>. No significant difference was observed between OSCC cases and controls (<italic>P</italic> = 0.433 for age; <italic>P</italic> = 0.242 for gender). However, the number of smokers and drinkers in cases was more than that in controls (smoking status: 40.32 vs. 34.86%, <italic>P =</italic> 0.047; drinking status: 41.44 <italic>vs.</italic> 30.89%, <italic>P &#x0003c;</italic> 0.001).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>General characteristics of participants</title></caption><table frame="box" rules="all"><thead><tr><th rowspan="2" align="left" valign="middle" colspan="1">Variables</th><th align="center" valign="middle" rowspan="1" colspan="1">Case</th><th align="center" valign="middle" rowspan="1" colspan="1">Control</th><th rowspan="2" align="center" valign="middle" colspan="1"><italic>P</italic><sup>a</sup></th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1"><italic>N</italic> (%)</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>N</italic> (%)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold>Participants</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">444 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">984 (100)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.433</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;60</td><td align="center" valign="middle" rowspan="1" colspan="1">203 (44.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">428 (43.50)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;60</td><td align="center" valign="middle" rowspan="1" colspan="1">241 (54.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">556 (56.50)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Gender</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.242</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Females</td><td align="center" valign="middle" rowspan="1" colspan="1">195 (43.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">465 (47.26)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Males</td><td align="center" valign="middle" rowspan="1" colspan="1">249 (56.08)</td><td align="center" valign="middle" rowspan="1" colspan="1">519 (52.74)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Smoking status</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.047</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Never</td><td align="center" valign="middle" rowspan="1" colspan="1">265 (59.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">641 (65.14)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Ever</td><td align="center" valign="middle" rowspan="1" colspan="1">179 (40.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">343 (34.86)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Drinking status</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Never</td><td align="center" valign="middle" rowspan="1" colspan="1">260 (58.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">680 (69.11)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Ever</td><td align="center" valign="middle" rowspan="1" colspan="1">184 (41.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">304 (30.89)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Two-sided &#x003c7;<sup>2</sup> test was used.</p></table-wrap-foot></table-wrap></sec><sec id="s2_2"><title>Associations of selected SNPs with OSCC risk</title><p>As shown in Table <xref ref-type="table" rid="T2">2</xref>, the preliminary information of the four selected SNPs was listed, and the genotype distributions among controls conformed to the Hardy&#x02013;Weinberg equilibrium (HWE) (<italic>P</italic> &#x0003e; 0.05). Among these four SNPs, rs217727 and rs2839701 were found to be related to the risk of OSCC in the additive model after adjusting for age, gender, smoking, and alcohol drinking status. The genotype distributions of rs217727 and rs2839701 and the association with the risk of OSCC were shown in Table <xref ref-type="table" rid="T3">3</xref>. Subjects with rs217727 TT genotype were more susceptible to the development of OSCC as compared to those carrying CC (OR = 1.89, 95% CI: 1.27&#x02013;2.82), while the rs2839701 GG carriers had a 1.64-fold elevated risk of developing OSCC as compared to individuals with the CC genotype (95% CI = 1.10&#x02013;2.43). Further combined analysis revealed that with an increased number of risk alleles, the risk of OSCC elevated significantly (<italic>P</italic><sub>trend</sub> &#x0003c; 0.001). The rs217727T and rs2839701G were speculated as risk alleles based on the primary effect of the individual locus. Subjects carrying &#x0201c;2-3&#x0201d; risk alleles showed a 2.22-fold elevated OSCC risk (95% CI = 1.56&#x02013;3.16) as compared to the &#x0201c;0&#x0201d; group (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>).</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Primary information and minor allele frequencies (MAFs) of selected SNPs</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">SNPs</th><th align="center" valign="middle" rowspan="1" colspan="1">Gene</th><th align="center" valign="middle" rowspan="1" colspan="1">Chr</th><th align="center" valign="middle" rowspan="1" colspan="1">Location</th><th align="center" valign="middle" rowspan="1" colspan="1">Base change</th><th align="center" valign="middle" rowspan="1" colspan="1">MAF<sup>a</sup> in dbSNP database (CHB)</th><th align="center" valign="middle" rowspan="1" colspan="1">MAF in our controls</th><th align="center" valign="middle" rowspan="1" colspan="1">HWE<sup>a</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Genotyping rate (%)</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>P</italic><sup><italic>b</italic></sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">rs217727</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>H19</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">11p15.5</td><td align="center" valign="middle" rowspan="1" colspan="1">exon</td><td align="center" valign="middle" rowspan="1" colspan="1">C&#x0003e;T</td><td align="center" valign="middle" rowspan="1" colspan="1">0.354</td><td align="center" valign="middle" rowspan="1" colspan="1">0.289</td><td align="center" valign="middle" rowspan="1" colspan="1">0.163</td><td align="center" valign="middle" rowspan="1" colspan="1">99.1</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.002</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">rs2839701</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>H19</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">11p15.5</td><td align="center" valign="middle" rowspan="1" colspan="1">exon</td><td align="center" valign="middle" rowspan="1" colspan="1">C&#x0003e;G</td><td align="center" valign="middle" rowspan="1" colspan="1">0.308</td><td align="center" valign="middle" rowspan="1" colspan="1">0.281</td><td align="center" valign="middle" rowspan="1" colspan="1">0.752</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.019</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">rs2067051</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>H19</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">11p15.5</td><td align="center" valign="middle" rowspan="1" colspan="1">exon</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x0003e;A</td><td align="center" valign="middle" rowspan="1" colspan="1">0.244</td><td align="center" valign="middle" rowspan="1" colspan="1">0.273</td><td align="center" valign="middle" rowspan="1" colspan="1">0.630</td><td align="center" valign="middle" rowspan="1" colspan="1">99.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.144</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">rs2251375</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>H19</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">11p15.5</td><td align="center" valign="middle" rowspan="1" colspan="1">intron</td><td align="center" valign="middle" rowspan="1" colspan="1">C&#x0003e;A</td><td align="center" valign="middle" rowspan="1" colspan="1">0.458</td><td align="center" valign="middle" rowspan="1" colspan="1">0.424</td><td align="center" valign="middle" rowspan="1" colspan="1">0.134</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">0.702</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>HWE = Hardy-Weinberg equilibrium. MAF = minor allele frequency.</p><p><sup>b</sup>Derived from logistic regression with an adjustment for age, sex, smoking and drinking status inadditive model.</p></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Genotypes of selected SNPs and OSCC risk in different models</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Positive SNPs</th><th align="center" valign="middle" rowspan="1" colspan="1">Calculation models</th><th align="center" valign="middle" rowspan="1" colspan="1">Case (%) (<italic>n</italic> = 444)</th><th align="center" valign="middle" rowspan="1" colspan="1">Control (%) (<italic>n</italic> = 984)</th><th align="center" valign="middle" rowspan="1" colspan="1">Adjusted OR <sup>a</sup>(95%CI)</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic><sup><italic>a</italic></sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">rs217727</td><td align="center" valign="middle" rowspan="1" colspan="1">CC</td><td align="center" valign="middle" rowspan="1" colspan="1">186 (41.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">488 (49.59)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">CT</td><td align="center" valign="middle" rowspan="1" colspan="1">194 (43.69)</td><td align="center" valign="middle" rowspan="1" colspan="1">423 (42.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.24 (0.97-1.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.080</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">TT</td><td align="center" valign="middle" rowspan="1" colspan="1">51 (11.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">73 (7.42)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.89 (1.27-2.82)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.002</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Dominant</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.34 (1.06-1.68)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.013</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Recessive</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.70 (1.16-2.49)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.006</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Additive</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.32 (1.11-1.58)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.002</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">rs2839701</td><td align="center" valign="middle" rowspan="1" colspan="1">CC</td><td align="center" valign="middle" rowspan="1" colspan="1">205 (46.17)</td><td align="center" valign="middle" rowspan="1" colspan="1">507 (51.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">CG</td><td align="center" valign="middle" rowspan="1" colspan="1">188 (42.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">402 (40.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.15 (0.91-1.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.248</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">51 (11.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">75 (7.62)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.64 (1.10-2.43)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.014</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Dominant</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.23 (0.98-1.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.075</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Recessive</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.53 (1.05-2.24)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.027</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Additive</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.23 (1.04-1.46)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.019</bold></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>ORs and 95% CIs were calculated after adjusting for age, sex, smoking and drinking status by using logistic regression analyses.</p></table-wrap-foot></table-wrap></sec><sec id="s2_3"><title>Stratification analysis</title><p>We also conducted stratification analyses and found that the risk effect of rs217727 was strong among elderly (age&#x02265; 60-year-old) (OR = 1.35, 95% CI: 1.07&#x02013;1.70) and nonsmokers (OR = 1.34, 95% CI: 1.07&#x02013;1.67); in addition, the association between rs2839701 variants and the risk of OSCC was rather profound among the elderly group (adjusted OR = 1.33, 95% CI: 1.06&#x02013;1.67), females (adjusted OR = 1.47, 95% CI: 1.13&#x02013;1.90), nonsmokers (adjusted OR = 1.29, 95% CI: 1.03&#x02013;1.61) and nondrinkers (adjusted OR = 1.25, 95% CI: 1.00&#x02013;1.56) (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref>). Moreover, no significant heterogeneity was observed in each subgroup (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 3</xref>).</p></sec><sec id="s2_4"><title>Biological function of rs2839701 on transcription activity</title><p>Bioinformatics prediction based on SNPinfo (<ext-link ext-link-type="uri" xlink:href="http://snpinfo.niehs.nih.gov/">http://snpinfo.niehs.nih.gov/</ext-link>) indicated that rs2839701 might influence the binding of the transcription factors of the two positive SNPs. Therefore, we performed functional experiments to investigate whether rs2839701 affected the transcription activity. Since rs2839701 was localized in the region enriched of the trimethylation of lysine 4 of the H3 (H3K4Me3) histone mark representing promoter activity (data from ENCODE), we evaluated its regulatory role by luciferase reporter assay. Both CAL27 and HN4 cells transfected with vectors containing the risk allele &#x0201c;G&#x0201d; showed a lower normalized luminescence as compared to the C allele, indicating an inhibitory effect of rs2839701 risk &#x0201c;G&#x0201d; allele on the transcription activity (CAL27: 9.43&#x000b1;2.71 <italic>vs.</italic> 4.19 &#x000b1; 2.18, <italic>P</italic> = 0.004; HN4: 8.03 &#x000b1; 2.08 <italic>vs.</italic>2.74 &#x000b1; 1.33, <italic>P</italic> = 0.001, Figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Rs2839701 C&#x0003e;G significantly inhibited transcription activity in OSCC cell lines</title><p>The results are shown as a ratio of firefly luciferase activity in relation to the control pRL-SV40 renilla luciferase. The mean fold change &#x000b1; SD for plasmid with different alleles are measured by defining the radio of empty control vector(mock) as 1. <sup>**</sup><italic>P</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="oncotarget-09-23915-g001"/></fig></sec><sec id="s2_5"><title><italic>In silico</italic> prediction of secondary structure caused by rs2839701</title><p><italic>In silico</italic> analyses performed by RNAfold predicted the influence of rs2839701 on the secondary structure of <italic>H19</italic>. As shown in Figure <xref ref-type="fig" rid="F2">2</xref>, the secondary structure was remarkably altered with rs2839701 C/G variants.</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title><italic>In silico</italic> prediction of secondary structure of <italic>H19</italic> with RNAfold</title><p>The arrow indicates alteration in structures caused by rs2839701 C/G variant.</p></caption><graphic xlink:href="oncotarget-09-23915-g002"/></fig></sec><sec id="s2_6"><title>Effects of rs2839701 on potential cancer-related gene</title><p>To further explore the biological effect of rs2839701, we investigated whether rs2839701 had an allele-specific correlation on the proximal cancer-related genes. The eQTL evidence was based on the public GTEx (<ext-link ext-link-type="uri" xlink:href="http://www.gtexportal.org/home/">http://www.gtexportal.org/home/</ext-link>) database was searched, and rs2839701C&#x0003e;G was found to remarkably correlate with the decreased expression of <italic>MRPL23-AS1</italic> (<italic>P</italic> &#x0003c; 0.001, Figure <xref ref-type="fig" rid="F3">3</xref>). <italic>MRPL23-AS1</italic> is a noncoding gene located 5.9 kb downstream of rs2839701. Next, we evaluated the expression of <italic>MRPL23-AS1</italic> by RT-PCR in 51 pairs of OSCC tissues and the adjacent normal tissues. Our results showed that the expression level of <italic>MRPL23-AS1</italic> in OSCC tissues was lower than that in normal tissues (<italic>P</italic> = 0.0125, Figure <xref ref-type="fig" rid="F4">4</xref>).</p><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>The genotype of rs2839701 was correlated with the expression of <italic>MRPL23-AS1</italic> in whole blood</title><p>(data from GTEx Portal).</p></caption><graphic xlink:href="oncotarget-09-23915-g003"/></fig><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>Expression analysis of <italic>MRPL23-AS1</italic> in 51 paired of OSCC tissues and adjacent normal tissues</title><p>The method of 2<sup>&#x02013;&#x00394;CT</sup> was used to calculate relative expression levels normalized by GAPDH.<sup>*</sup><italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="oncotarget-09-23915-g004"/></fig></sec></sec><sec id="s3"><title>DISCUSSION</title><p>Long noncoding RNAs act as regulators of several biological processes including carcinogenesis. Emerging evidence has indicated that SNPs of lncRNAs could influence the functions and expression of cancer-related genes, thereby contributing to cancer susceptibility. For example, Du <italic>et al.</italic> [<xref rid="R22" ref-type="bibr">22</xref>] identified a gastric cancer susceptibility SNP rs4759314 on lncRNA <italic>HOTAIR</italic> could regulate the expression of <italic>HOTAIR</italic> and the proximal gene <italic>HOXC11</italic>. Herein, a case-control study was conducted to investigate whether the functional SNPs in <italic>H19</italic> were associated with the risk of OSCC. Among the four SNPs, rs2839701 C&#x0003e;G and rs217727 C&#x0003e;T were found to be correlated with increased OSCC risk independently and jointly.</p><p>The biological mechanisms underlying disease-associated SNPs have gained increasing attention with respect to molecular epidemiology. For example, Li <italic>et al.</italic> reported that rs3764482 C&#x0003e;T variant was associated with colorectal cancer risk by modulating the TGF-&#x003b2; signaling [<xref rid="R23" ref-type="bibr">23</xref>]. rs6695837, localized at 2kb upstream of the <italic>LAMC1</italic> gene, affected the <italic>LAMC1</italic> promoter activity and contributed to colorectal cancer susceptibility [<xref rid="R24" ref-type="bibr">24</xref>]. The SNP rs2839701 resides on the exon 4 of <italic>H19</italic>. Secondary structure plays a major role in the function of lncRNAs [<xref rid="R25" ref-type="bibr">25</xref>]. We performed <italic>in silico</italic> analyses by RNAfold and found that the secondary structure of <italic>H19</italic> altered with rs2839701 C/G alleles. In addition, based on the ENCODE data, rs2839701 localized in the region exhibiting the promoter activity. The luciferase reporter assay showed an inhibitory effect of rs2839701 risk &#x0201c;G&#x0201d; allele on transcription activity. We hypothesized that the risk SNP rs2839701 had an allele-specific correlation on the nearby genes. Intriguingly, rs2839701 risk &#x0201c;G&#x0201d; allele was significantly associated with low expression levels of 5.9 kb downstream gene <italic>MRPL23-AS1</italic>, which was less expressed in the OSCC tissues. Our results suggested that rs2839701 inhibited the transcriptional activity that might be associated with the decreased expression of a potential tumor suppressor gene <italic>MRPL23-AS1</italic> and raised the risk of OSCC. Furthermore, the SNP rs2839698, with a high linkage disequilibrium (<italic>r</italic><sup><italic>2</italic></sup> &#x0003e; 0.8) of rs2839701, has been evaluated for the genetic susceptibility to several cancer types. A meta-analysis performed by Chu <italic>et al.</italic> [<xref rid="R26" ref-type="bibr">26</xref>] demonstrated that rs2839698 was related to the risk of digestive system cancers, which was in agreement with the results of the current study on rs2839701.</p><p>Reportedly, the relationship between rs217727 polymorphism and the susceptibility to cancers in Chinese population have not yet achieved a consensus. The <italic>H19</italic> rs217727 polymorphism has been shown to be associated with the risk of gastric cancer [<xref rid="R20" ref-type="bibr">20</xref>], breast cancer [<xref rid="R18" ref-type="bibr">18</xref>], and bladder cancer [<xref rid="R19" ref-type="bibr">19</xref>]; however, no significant association was observed between rs217727 and colorectal cancer risk [<xref rid="R21" ref-type="bibr">21</xref>] in the Chinese population. Lu <italic>et al.</italic> [<xref rid="R27" ref-type="bibr">27</xref>]conducted a meta-analysis and suggested that rs217727 polymorphism did not correlate with the susceptibility to cancers in Chinese individuals. Nevertheless, our study showed that rs217727 C&#x0003e;T exhibited a significantly increased risk for the development of OSCC. Therefore, cumulative meta-analysis is warranted in order to obtain definitive results.</p><p>Nonetheless, several limitations should be considered in the present study. First, the allele-specific correlation between rs2839701 and <italic>MRPL23-AS1</italic> was based on the GTEx database; however, we did not evaluate this correlation in OSCC samples. Second, we failed to retrieve the predicted transcription factors binding site (TFBS) of rs217727 by SNPinfo; thus, further functional experiments are essential to clarify the biological mechanisms of rs217727 on the development of OSCC. Third, our study was focused on the molecular epidemiology of OSCC development, and the investigation on the potential mechanism of rs2839701 C&#x0003e;G was preliminary. More experimental evidences are needed to verify the predicted data. Final, this one-stage study was conducted with a relatively small sample size, and hence, large-scale studies are imperative to validate our findings.</p><p>In conclusion, we identified two SNPs, rs2839701 and rs217727, associated with OSCC susceptibility in a Chinese population. The functional SNP rs2839701 C&#x0003e;G may alter the secondary structure of <italic>H19</italic> and influence the function, which might partially explain the OSCC genetic susceptibility. In addition, rs2839701 genetic variant inhibited the transcriptional activity and was correlated with the decreased expression of downstream gene <italic>MRPL23-AS1</italic> that is downregulated in OSCC. Therefore, our results suggested that the SNPs in <italic>H19</italic> might serve as potential biomarkers of OSCC prediction.</p></sec><sec id="s4"><title>MATERIALS AND METHODS</title><sec id="s4_1"><title>Study population</title><p>In the present study, we enrolled 444 OSCC cases and 984 controls. From January 2009 to May 2013, we recruited 444 histopathologically confirmed patients from Jiangsu Stomatological Hospital and Nanjing Medical University First Affiliated Hospital, excluding those with metastatic tumors and received chemotherapy or radiotherapy. Age- (&#x000b1;5 years) and gender-matched controls were chosen randomly from a community-based disease screening project, including &#x0003e;30,000 individuals during the same period, which was carried out in the Jiangsu Province. The participants were interviewed personally by uniformly trained interviewers to obtain general and lifestyle information with respect to age, gender, smoking, and alcohol drinking. Moreover, withdrew a 5 ml venous blood sample from each participant for genomic DNA isolation and genotyping. Every participant signed an informed consent. The present study was approved by the Ethics Committee of Nanjing Medical University.</p></sec><sec id="s4_2"><title>SNP selection and genotype identification</title><p>The region including 2 kb upstream of the <italic>H19</italic> gene was screened by the HapMap database (version: phase II + III Feb 09, dbSNP b126) in Chinese Han population (CHB), according to the following criteria: <italic>P</italic> for Hardy&#x02013;Weinberg equilibrium (HWE) &#x02265;0.05; genotyping rate &#x02265;90%; minor allele frequency (MAF) &#x02265;0.05. Thus, 9 SNPs were selected. Then, according to an online function-scoring software (<ext-link ext-link-type="uri" xlink:href="http://www.regulomedb.org/">http://www.regulomedb.org/</ext-link>), 7 potentially functional SNPs were included for their RegulomeDB score &#x02264;4. This database was supported by Stanford University. Every variant was graded by its function on the binding of transcription factors and the expression quantitative trait. The higher the score, the lower the function. Lastly, four tagging SNPs were selected by Haploview 4.2 software according to <italic>r</italic><sup><italic>2</italic></sup> for linkage disequilibrium (LD) &#x0003c;0.8.</p><p>Genomic DNA was extracted from peripheral blood leukocytes by proteinase K digestion and phenol-chloroform methods. Sequenom MassARRAY iPLEX platform was used for genotyping the SNPs.</p></sec><sec id="s4_3"><title>Luciferase reporter assay</title><p>A 207-bp human genomic region (UCSC hg38, chr11: 1995795&#x02013;1996001), surrounding the functional candidate SNP rs2839701 C and G alleles, was synthesized and inserted into the pGL3-promoter plasmids (Promega), respectively, digested with 5&#x02032;-<italic>SacI</italic> and 3&#x02032;-<italic>XhoI</italic>. The constructs were validated by DNA sequencing.</p></sec><sec id="s4_4"><title>Construct risk allele (C)</title><p>CTAGAGATAGCGACACGTGGGTGGGATGGGGGCAGGGTGCTCGGGGGCCTGGAGGCTTCCGGAAGGAGCGCTGGTGCTCACCTTC<bold><underline>C</underline></bold>AGAGCCGATTCCTGAGTCAGGTAGTGCAGTGGTTGTAAAGTGCAGCATATTCATTTCCAAGCTAGAGGGTTTTGTGTCCGGATTCAAAGGCCCAGGCTTGAGCTGGGTAGCACCATTTCTG</p></sec><sec id="s4_5"><title>Construct wild allele (G)</title><p>CTAGAGATAGCGACACGTGGGTGGGATGGGGGCAGGGTGCTCGGGGGCCTGGAGGCTTCCGGAAGGAGCGCTGGTGCTCACCTTC<bold><underline>G</underline></bold>AGAGCCGATTCCTGAGTCAGGTAGTGCAGTGGTTGTAAAGTGCAGCATATTCATTTCCAAGCTAGAGGGTTTTGTGTCCGGATTCAAAGGCCCAGGCTTGAGCTGGGTAGCACCATTTCTG.</p><p>Cal-27 and HN-4 cells were cultured in a humidified incubator at 37&#x000b0;C with 5% CO<sub>2</sub>. The medium used for cell culture was DMEM containing 10% fetal bovine serum. Cells were seeded in 24-well plates with 5 &#x000d7; 10<sup>4</sup> cells/well and subsequently transfected with 500 ng luciferase reporter plasmids by Lipofectamine 2000 (Invitrogen) after 24 h. 10 ng of Renilla luciferase pRL-SV40 plasmid (Promega, Wisconsin, USA) was cotransfected per well as an internal control. 48 h post-transfection, the cells were analyzed for the luciferase activities by the Dual-Luciferase Reporter Assay System (Promega). All the reporter assays were conducted at least three times in quintuplicate (five technical replicates each).</p></sec><sec id="s4_6"><title><italic>In silico</italic> prediction of secondary structure change</title><p>To investigate whether SNP rs2839701 changed the secondary structure of <italic>H19</italic>, we performed an <italic>in silico</italic> analyses using the online prediction tool, RNAfold (<ext-link ext-link-type="uri" xlink:href="http://nhjy.hzau.edu.cn/kech/swxxx/jakj/dianzi/Bioinf4/miRNA/miRNA1.htm">http://nhjy.hzau.edu.cn/kech/swxxx/jakj/dianzi/Bioinf4/miRNA/miRNA1.htm</ext-link>).</p></sec><sec id="s4_7"><title>Analysis of <italic>MRPL23-AS1</italic> expression levels in OSCC tissues</title><p>Total RNAs were extracted from 51 OSCC specimens, and 51 paired adjacent normal tissues by TRIzol (Invitrogen, CA, USA). The cDNA was synthesized using the PrimeScript RT Master Mix Kit (TaKaRa, Dalian, China). Subsequently, we evaluated the expression levels of <italic>MRPL23-AS1</italic> byreal-time reverse transcription PCR utilizing the SYBR Premix EX Taq Kit (TaKaRa Biotechnology, Japan).The expression level of the gene was normalized to <italic>GAPDH</italic> [<xref rid="R24" ref-type="bibr">24</xref>]. The primers used were as follows: <italic>MRPL23-AS1</italic> (forward,5&#x02032;-GAGGTTCCTGTGGGAGTTGG-3&#x02032;; reverse, 5&#x02032;-TCACCCTGTCTTCGCCTGT-3&#x02032;) and <italic>GAPDH</italic> (forward, 5&#x02032;-GGGCTGCTTTTAACTCTGGT-3&#x02032;; reverse, 5&#x02032;-GCAGGTTTTTCTAGACGG-3&#x02032;). The amplification program was set as 95&#x000b0;C for 30s, followed by 40 cycles of 95&#x000b0;C for 5s and 60&#x000b0;C for 30s on the ABI 7900 HT real-time PCR system (Applied Biosystems, USA). The method of 2<sup>-&#x00394;CT</sup> [<xref rid="R28" ref-type="bibr">28</xref>] was used to calculate the relative expression levels, and all reactions were performed in triplicate.</p></sec><sec id="s4_8"><title>Statistical analysis</title><p>The differences in general characteristics between OSCC cases and controls were evaluated by &#x003c7;<sup>2</sup> test. The goodness-of-fit &#x003c7;<sup>2</sup> test was used to calculate the HWE in the control subjects. Logistic regression estimated the associations between genotypes of selected SNPs and OSCC risk by assessing the odds ratios (ORs) and 95% confidence intervals (CIs). The &#x003c7;<sup>2</sup>-based <italic>Q</italic>-test was used to compute the heterogeneity between subgroups. <italic>P</italic> &#x0003c; 0.05 was considered as statistically significant. All the statistical analyses were two-sided and conducted with Stata software (version 11.0; Stata Corporation, TX, USA).</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>SUPPLEMENTARY MATERIALS TABLES</title><supplementary-material content-type="local-data" id="SD1"><media mimetype="application" mime-subtype="pdf" xlink:href="oncotarget-09-23915-s001.pdf" orientation="portrait" id="d35e1276" position="anchor"/></supplementary-material></sec></body><back><fn-group><fn fn-type="con"><p><bold>Author contributions</bold></p><p>ZY, YY and BZ carried out the experiments and drafted the manuscript; LM and LW collected data, analyzed and interpreted the results; KZ and YJ were involved in the statistical analysis; RW and HM critically reviewed the manuscript; NC and HY managed the experimental design, reviewed the manuscript and provided funding support. All authors read and approved the final manuscript.</p></fn><fn fn-type="COI-statement"><p><bold>CONFLICTS OF INTEREST</bold></p><p>No declared.</p></fn><fn fn-type="supported-by"><p><bold>FUNDING</bold></p><p>This work was supported by National Natural Science Foundation of China (81672678 and 81302361), Innovation Project for Graduate Student of Jiangsu Province (KYLX16_1121), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, 2014-37) and The Project of Invigorating Health Care through Science, Technology and Education (Jiangsu Provincial Medical Youth Talent).</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term>OSCC</term><def><p>oral squamous cell carcinoma</p></def></def-item><def-item><term>GWAS</term><def><p>genome-wide association study</p></def></def-item><def-item><term>SNPs</term><def><p>single nucleotide polymorphisms</p></def></def-item><def-item><term>lncRNA</term><def><p>long non-coding RNA</p></def></def-item><def-item><term>OR</term><def><p>odds ratio</p></def></def-item><def-item><term>CI</term><def><p>confidence interval</p></def></def-item><def-item><term>ENCODE</term><def><p>Encyclopedia of DNA Elements</p></def></def-item><def-item><term>GTEx</term><def><p>Genotype-Tissue Expression</p></def></def-item><def-item><term>eQTL</term><def><p>expression quantitative trait loci</p></def></def-item><def-item><term>HWE</term><def><p>Hardy&#x02013;Weinberg equilibrium</p></def></def-item><def-item><term>LD</term><def><p>linkage disequilibrium</p></def></def-item><def-item><term>H3K4Me3</term><def><p>tri-methylation of lysine 4 of the H3</p></def></def-item><def-item><term>TFBS</term><def><p>transcription factors binding site</p></def></def-item></def-list></glossary><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shpitzer</surname><given-names>T</given-names></name><name name-style="western"><surname>Bahar</surname><given-names>G</given-names></name><name name-style="western"><surname>Feinmesser</surname><given-names>R</given-names></name><name name-style="western"><surname>Nagler</surname><given-names>RM</given-names></name></person-group><article-title>A comprehensive salivary analysis for oral cancer diagnosis</article-title><source>J Cancer Res Clin Oncol</source><year>2007</year><volume>133</volume><fpage>613</fpage><lpage>617</lpage><pub-id pub-id-type="pmid">17479291</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>R</given-names></name><name name-style="western"><surname>Baade</surname><given-names>PD</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name><name name-style="western"><surname>Yu</surname><given-names>XQ</given-names></name><name name-style="western"><surname>He</surname><given-names>J</given-names></name></person-group><article-title>Cancer statistics in China, 2015</article-title><source>CA Cancer J Clin</source><year>2016</year><volume>66</volume><fpage>115</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">26808342</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Markopoulos</surname><given-names>AK</given-names></name></person-group><article-title>Current aspects on oral squamous cell carcinoma</article-title><source>Open Dent J</source><year>2012</year><volume>6</volume><fpage>126</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">22930665</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>H</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H</given-names></name><name name-style="western"><surname>Chu</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shen</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>N</given-names></name></person-group><article-title>Genetic variants at 10q23 are associated with risk of head and neck cancer in a Chinese population</article-title><source>Oral oncol</source><year>2013</year><volume>49</volume><fpage>332</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">23151416</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lesseur</surname><given-names>C</given-names></name><name name-style="western"><surname>Diergaarde</surname><given-names>B</given-names></name><name name-style="western"><surname>Olshan</surname><given-names>AF</given-names></name><name name-style="western"><surname>Wunsch-Filho</surname><given-names>V</given-names></name><name name-style="western"><surname>Ness</surname><given-names>AR</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name><name name-style="western"><surname>Lacko</surname><given-names>M</given-names></name><name name-style="western"><surname>Eluf-Neto</surname><given-names>J</given-names></name><name name-style="western"><surname>Franceschi</surname><given-names>S</given-names></name><name name-style="western"><surname>Lagiou</surname><given-names>P</given-names></name><name name-style="western"><surname>Macfarlane</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Richiardi</surname><given-names>L</given-names></name><name name-style="western"><surname>Boccia</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer</article-title><source>Nat Genet</source><year>2016</year><volume>48</volume><fpage>1544</fpage><lpage>1550</lpage><pub-id pub-id-type="pmid">27749845</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKay</surname><given-names>JD</given-names></name><name name-style="western"><surname>Truong</surname><given-names>T</given-names></name><name name-style="western"><surname>Gaborieau</surname><given-names>V</given-names></name><name name-style="western"><surname>Chabrier</surname><given-names>A</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>SC</given-names></name><name name-style="western"><surname>Byrnes</surname><given-names>G</given-names></name><name name-style="western"><surname>Zaridze</surname><given-names>D</given-names></name><name name-style="western"><surname>Shangina</surname><given-names>O</given-names></name><name name-style="western"><surname>Szeszenia-Dabrowska</surname><given-names>N</given-names></name><name name-style="western"><surname>Lissowska</surname><given-names>J</given-names></name><name name-style="western"><surname>Rudnai</surname><given-names>P</given-names></name><name name-style="western"><surname>Fabianova</surname><given-names>E</given-names></name><name name-style="western"><surname>Bucur</surname><given-names>A</given-names></name><etal/></person-group><article-title>A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium</article-title><source>PLoS Genet</source><year>2011</year><volume>7</volume><fpage>e1001333</fpage><pub-id pub-id-type="pmid">21437268</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>KC</given-names></name><name name-style="western"><surname>Chang</surname><given-names>HY</given-names></name></person-group><article-title>Molecular mechanisms of long noncoding RNAs</article-title><source>Mol Cell</source><year>2011</year><volume>43</volume><fpage>904</fpage><lpage>914</lpage><pub-id pub-id-type="pmid">21925379</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jing</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>XW</given-names></name><name name-style="western"><surname>Pan</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Gao</surname><given-names>SS</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>SL</given-names></name><name name-style="western"><surname>Liang</surname><given-names>CZ</given-names></name><name name-style="western"><surname>Tu</surname><given-names>JC</given-names></name></person-group><article-title>The Significance of Long Noncoding RNA H19 in Predicting Progression and Metastasis of Cancers: A Meta-Analysis</article-title><source>Biomed Res Int</source><year>2016</year><volume>2016</volume><fpage>5902678</fpage><pub-id pub-id-type="pmid">27672656</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>CM</given-names></name><name name-style="western"><surname>Lin</surname><given-names>PM</given-names></name><name name-style="western"><surname>Lin</surname><given-names>HC</given-names></name><name name-style="western"><surname>Lai</surname><given-names>CC</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CH</given-names></name><name name-style="western"><surname>Lin</surname><given-names>SF</given-names></name><name name-style="western"><surname>Yang</surname><given-names>MY</given-names></name></person-group><article-title>Altered Expression of Imprinted Genes in Squamous Cell Carcinoma of the Head and Neck</article-title><source>Anticancer Res</source><year>2016</year><volume>36</volume><fpage>2251</fpage><lpage>2258</lpage><pub-id pub-id-type="pmid">27127130</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Ning</surname><given-names>N</given-names></name><name name-style="western"><surname>Jin</surname><given-names>X</given-names></name></person-group><article-title>The lncRNA H19 Promotes Cell Proliferation by Competitively Binding to miR-200a and Derepressing beta-Catenin Expression in Colorectal Cancer</article-title><source>Biomed Res Int</source><year>2017</year><volume>2017</volume><fpage>2767484</fpage><pub-id pub-id-type="pmid">28164117</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Jia</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>An</surname><given-names>J</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Lu</surname><given-names>D</given-names></name></person-group><article-title>miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>31958</fpage><lpage>31984</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.5579">https://doi.org/10.18632/oncotarget.5579</ext-link></comment><pub-id pub-id-type="pmid">26376677</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Ma</surname><given-names>F</given-names></name><name name-style="western"><surname>Tang</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Wu</surname><given-names>XC</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>MD</given-names></name><name name-style="western"><surname>Weng</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JD</given-names></name><name name-style="western"><surname>Quan</surname><given-names>ZW</given-names></name></person-group><article-title>Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer</article-title><source>J Exp Clin Cancer Res</source><year>2016</year><volume>35</volume><fpage>160</fpage><pub-id pub-id-type="pmid">27716361</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>T</given-names></name><name name-style="western"><surname>Wu</surname><given-names>QF</given-names></name><name name-style="western"><surname>Wang</surname><given-names>WX</given-names></name></person-group><article-title>Long Noncoding RNA H19-Derived miR-675 Enhances Proliferation and Invasion via RUNX1 in Gastric Cancer Cells</article-title><source>Oncol Res</source><year>2016</year><volume>23</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">26931432</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shastry</surname><given-names>BS</given-names></name></person-group><article-title>SNPs: impact on gene function and phenotype</article-title><source>Methods Mol Biol</source><year>2009</year><volume>578</volume><fpage>3</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">19768584</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>G</given-names></name></person-group><article-title>Human genetics. GTEx detects genetic effects</article-title><source>Science</source><year>2015</year><volume>348</volume><fpage>640</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">25953996</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nicolae</surname><given-names>DL</given-names></name><name name-style="western"><surname>Gamazon</surname><given-names>E</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Duan</surname><given-names>S</given-names></name><name name-style="western"><surname>Dolan</surname><given-names>ME</given-names></name><name name-style="western"><surname>Cox</surname><given-names>NJ</given-names></name></person-group><article-title>Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS</article-title><source>PLoS Genet</source><year>2010</year><volume>6</volume><fpage>e1000888</fpage><pub-id pub-id-type="pmid">20369019</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shar</surname><given-names>NA</given-names></name><name name-style="western"><surname>Vijayabaskar</surname><given-names>MS</given-names></name><name name-style="western"><surname>Westhead</surname><given-names>DR</given-names></name></person-group><article-title>Cancer somatic mutations cluster in a subset of regulatory sites predicted from the ENCODE data</article-title><source>Mol Cancer</source><year>2016</year><volume>15</volume><fpage>76</fpage><pub-id pub-id-type="pmid">27887606</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yan</surname><given-names>R</given-names></name><name name-style="western"><surname>Duan</surname><given-names>F</given-names></name><name name-style="western"><surname>Song</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name></person-group><article-title>Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population</article-title><source>Medicine</source><year>2016</year><volume>95</volume><fpage>e2771</fpage><pub-id pub-id-type="pmid">26886624</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hua</surname><given-names>Q</given-names></name><name name-style="western"><surname>Lv</surname><given-names>X</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chu</surname><given-names>H</given-names></name><name name-style="western"><surname>Du</surname><given-names>M</given-names></name><name name-style="western"><surname>Gong</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population</article-title><source>Mutagenesis</source><year>2016</year><volume>31</volume><fpage>531</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">27091055</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Tang</surname><given-names>R</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luo</surname><given-names>D</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name></person-group><article-title>Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>15311</fpage><lpage>15320</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.3840">https://doi.org/10.18632/oncotarget.3840</ext-link></comment><pub-id pub-id-type="pmid">25944697</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Hua</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jin</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Du</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Chu</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name></person-group><article-title>Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>25470</fpage><lpage>25477</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.8330">https://doi.org/10.18632/oncotarget.8330</ext-link></comment><pub-id pub-id-type="pmid">27027436</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ge</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Ma</surname><given-names>G</given-names></name><name name-style="western"><surname>Chu</surname><given-names>H</given-names></name><name name-style="western"><surname>Tong</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Qiang</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>The association analysis of lncRNA HOTAIR genetic variants and gastric cancer risk in a Chinese population</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>31255</fpage><lpage>31262</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.5158">https://doi.org/10.18632/oncotarget.5158</ext-link></comment><pub-id pub-id-type="pmid">26384301</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zou</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lou</surname><given-names>J</given-names></name><name name-style="western"><surname>Ke</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tian</surname><given-names>J</given-names></name><name name-style="western"><surname>Zou</surname><given-names>D</given-names></name><name name-style="western"><surname>Peng</surname><given-names>X</given-names></name><etal/></person-group><article-title>A low-frequency variant in SMAD7 modulates TGF-beta signaling and confers risk for colorectal cancer in Chinese population</article-title><source>Mol Carcinog</source><year>2017</year><volume>56</volume><fpage>1798</fpage><lpage>1807</lpage><pub-id pub-id-type="pmid">28218435</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lou</surname><given-names>J</given-names></name><name name-style="western"><surname>Gong</surname><given-names>J</given-names></name><name name-style="western"><surname>Ke</surname><given-names>J</given-names></name><name name-style="western"><surname>Tian</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Chang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>R</given-names></name><name name-style="western"><surname>Miao</surname><given-names>X</given-names></name></person-group><article-title>A functional polymorphism located at transcription factor binding sites, rs6695837 near LAMC1 gene, confers risk of colorectal cancer in Chinese populations</article-title><source>Carcinogenesis</source><year>2017</year><volume>38</volume><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">28039327</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pegueroles</surname><given-names>C</given-names></name><name name-style="western"><surname>Gabaldon</surname><given-names>T</given-names></name></person-group><article-title>Secondary structure impacts patterns of selection in human lncRNAs</article-title><source>BMC Biol</source><year>2016</year><volume>14</volume><fpage>60</fpage><pub-id pub-id-type="pmid">27457204</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>M</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>W</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mao</surname><given-names>L</given-names></name><name name-style="western"><surname>Tian</surname><given-names>T</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Gao</surname><given-names>H</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>X</given-names></name></person-group><article-title>Quantitative assessment of polymorphisms in H19 lncRNA and cancer risk: a meta-analysis of 13,392 cases and 18,893 controls</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>78631</fpage><lpage>78639</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.12530">https://doi.org/10.18632/oncotarget.12530</ext-link></comment><pub-id pub-id-type="pmid">27732938</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tan</surname><given-names>L</given-names></name><name name-style="western"><surname>Shen</surname><given-names>N</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Association of lncRNA H19 rs217727 polymorphism and cancer risk in the Chinese population: a meta-analysis</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>59580</fpage><lpage>59588</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.10936">https://doi.org/10.18632/oncotarget.10936</ext-link></comment><pub-id pub-id-type="pmid">27486980</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Dong</surname><given-names>J</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dai</surname><given-names>J</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Jin</surname><given-names>G</given-names></name><name name-style="western"><surname>Han</surname><given-names>J</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Shen</surname><given-names>H</given-names></name><etal/></person-group><article-title>Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma</article-title><source>Int J Cancer</source><year>2015</year><volume>137</volume><fpage>1679</fpage><lpage>1690</lpage><pub-id pub-id-type="pmid">25845839</pub-id></element-citation></ref></ref-list></back></article>